Boan Biotech has raised 682 million yuan ($106 million) from a host of investors including YuanBio Venture Capital. In a separate development, Qinbaobao has secured its Series D funding of 250 million yuan ($39 million) from Fortune Capital and Shenzhen Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
